News

Quest Diagnostics price target raised to $189 from $178 at Mizuho
Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $189 from $178 and keeps an Outperform rating on the shares. The firm ...
Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors
Shares of Quest Diagnostics Inc. DGX slid 2.74% to $159.80 Tuesday, on what proved to be an all-around dismal trading session ...
Leerink Partnrs Issues Pessimistic Estimate for DGX Earnings
Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...
Quest Diagnostics (NYSE:DGX) Earns Buy Rating from Analysts at Redburn Atlantic
Redburn Atlantic began coverage on shares of Quest Diagnostics (NYSE:DGX – Free Report) in a report issued on Wednesday morning, MarketBeat reports. The firm issued a buy rating and a $195.00 price ...
Investor's Business Daily on MSN5d
Dow Jones Futures Dive As China Retaliation Vs. Trump Tariffs Raises Recession Fears
The S&P 500 and Nasdaq had their worst losses since 2020 while President Trump said his tariff plan is "going very well." The jobs report and Fed chief Jerome Powell loom.
Investor's Business Daily on MSN5d
Why IBD Stock Of The Day Quest Diagnostics Sidestepped The Sell-Off
Quest Diagnostics is Thursday's IBD Stock Of The Day. Shares are lingering in a buy zone, helped by a Texas court's ruling.